Israel Gp Ltd. Orbimed serves as Executive at BiomX Inc., where they oversee executive responsibilities. Since joining the company, Israel Gp Ltd. Orbimed has executed 10 insider transactions totaling $2.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 27, 2023 involved purchasing 348,000 shares valued at $87.0K.
Israel Gp Ltd. Orbimed currently holds 3,161,489 shares of BiomX Inc. (PHGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Israel Gp Ltd. Orbimed has been a net seller of PHGE stock. They have purchased $208.3K and sold $2.2M worth of shares.
Israel Gp Ltd. Orbimed's most recent insider trade was on Feb 27, 2023, when they purchased 348,000 shares at $0.25 per share.
Get notified when new Form 4 filings are submitted
| $17.35 |
| Discretionary |
| Feb 12, 2021 | ACET | $5.5M | Award | 420,299 | $13.00 | Discretionary |
| Feb 12, 2021 | ACET | $1.4M | Award | 104,050 | $13.00 | Discretionary |
| Dec 2, 2020 | NVUS | $2.2M | Sale | 103,200 | $21.60 | Discretionary |
| Dec 19, 2019 | PHGE | $31.1K | Purchase | 3,500 | $8.90 | Discretionary |
| Dec 18, 2019 | PHGE | $4.5K | Purchase | 500 | $8.93 | Discretionary |
| Dec 9, 2019 | PHGE | $52.1K | Purchase | 6,000 | $8.68 | Discretionary |
| Dec 6, 2019 | PHGE | $6.4K | Purchase | 800 | $8.00 | Discretionary |
| Dec 5, 2019 | PHGE | $27.2K | Purchase | 3,400 | $7.99 | Discretionary |